TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 22 | 7 | 41 | 24 | 15 | -38 | 12 |
| P | %wins | 100 | 50 | 100 | 100 | 100 | 0 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/7/07 18:46 | 12/4/07 | DSCI | Derma Sciences, Inc. | PA | Health | MdEq | Surgical & Medical Instrument | Stafford C Richard | NJ | D | P | 16 | 0.6500 | 0 | 25 | 71 | 60 | D | 8 | -12 | -11 | -10 | 8 | -4 | 3 | 5 | 17 | 17 | 50 | 39 | 16 | -66 | |
8/26/05 12:16 | 8/23/05 | VRA | Viragen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stafford C Richard | NJ | D | P | 31 | 0.6200 | 0 | 50 | 100 | 100 | D | |||||||||||||||
5/11/05 12:42 | 4/5/05 | VRA | Viragen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stafford C Richard | NJ | D | P.am | 30 | 0.6387 | 0 | 47 | 999% | 50 | D | |||||||||||||||
5/10/05 14:04 | 5/9/05 | VRA | Viragen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Stafford C Richard | NJ | D | P | 16 | 0.6200 | 0 | 25 | 815 | 28 | D | |||||||||||||||
1/6/05 14:08 | 1/5/05 | DSCI | Derma Sciences Inc | PA | Health | Drug | Pharmaceutical Preparations | Stafford C Richard | NJ | D | P.d | 18 | 0.5000 | 0 | 35 | New | 35 | D | -12 | -51 | -24 | -22 | -4 | -12 | -2 | -21 | 26 | -4 | 32 | 9 | 13 | -9 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |